1 |
Park, S. J., Ahmad, F., Um, J. H., Brown, A. L., Xu, X., Kang, H., Ke, H., Feng, X., Ryall, J. and Philp, A. 2017. Specific Sirt1 activator-mediated improvement in glucose homeostasis requires Sirt1-independent activation of AMPK. EBio Medicine 18, 128-138.
|
2 |
Lee, S. H., Lee, J. H., Lee, H. Y. and Min, K. J. 2019. Sirtuin signaling in cellular senescence and aging. BMB Reports 52, 24.
DOI
|
3 |
Rahnasto-Rilla, M., Tyni, J. and Lahtela-Kakkonen, M. 2020. Sirtuin inhibitors and activators. Chem. Epigenet. 55-92.
|
4 |
Razgonova, M. P., Zakharenko, A. M., Golokhvast, K. S., Thanasoula, M., Sarandi, E., Nikolouzakis, K., Fragkiadaki, P., Tsoukalas, D., Spandidos, D. A. and Tsatsakis, A. 2020. Telomerase and telomeres in aging theory and chronographic aging theory. Mol. Med. Rep. 22, 1679-1694.
DOI
|
5 |
Ren, Z., He, H., Zuo, Z., Xu, Z., Wei, Z. and Deng, J. 2019. The role of different SIRT1-mediated signaling pathways in toxic injury. Cell Mol. Biol. Lett. 24, 36.
DOI
|
6 |
Shay, J. W. and Wright, W. E. 2000. Hayflick, his limit, and cellular ageing. Nat. Rev. Mol. Cell Biol. 1, 72-76.
DOI
|
7 |
Shi, G., Liu, D., Zhou, B., Liu, Y., Hao, B., Yu, S., Wu, L., Wang, M., Song, Z. and Wu, C. 2020. Ginsenoside Rb1 alleviates oxidative low-density lipoprotein-induced vascular endothelium senescence via the SIRT1/Beclin-1/Autophagy Axis. J. Cardiovasc. Pharmacol. 75, 155-167.
DOI
|
8 |
Soni, N. O. 2017. SIRT-1 ACTIVATORS-IN DIABETIC NEPHROPATHY.
|
9 |
Sunthonkun, P., Palajai, R., Somboon, P., Suan, C. L., Ungsurangsri, M. and Soontorngun, N. 2019. Life-span extension by pigmented rice bran in the model yeast Saccharomyces cerevisiae. Sci. Rep. 9, 1-16.
DOI
|
10 |
Tichon, A., Eitan, E., Kurkalli, B., Braiman, A., Gazit, A., Slavin, S., Beith-Yannai, E. and Priel, E. 2013. Oxidative stress protection by novel telomerase activators in mesenchymal stem cells derived from healthy and diseased individuals. Curr. Mol. Med. 13, 1010-1022.
DOI
|
11 |
Tran, D., Bergholz, J., Zhang, H., He, H., Wang, Y., Zhang, Y., Li, Q., Kirkland, J. L. and Xiao, Z. X. 2014. Insulin-like growth factor-1 regulates the SIRT 1-p53 pathway in cellular senescence. Aging Cell 13, 669-678.
DOI
|
12 |
Baar, M. P., Brandt, R. M., Putavet, D. A., Klein, J. D., Derks, K. W., Bourgeois, B. R., Stryeck, S., Rijksen, Y., van Willigenburg, H. and Feijtel, D. A. 2017. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell 169, 132-147. e116.
DOI
|
13 |
Borra, M. T., Smith, B. C. and Denu, J. M. 2005. Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 280, 17187-17195.
DOI
|
14 |
Buffard, T. and Ferbeyre, G. 2020. Senolytics Target Senescent Cells and Improve Aging and Age-Related Diseases.63-84. Senolytics in Disease, Ageing and Longevity: Springer.
|
15 |
Chau, M. N., El Touny, L. H., Jagadeesh, S. and Banerjee, P. P. 2007. Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3. Carcinogenesis 28, 2282-2290.
DOI
|
16 |
de Jesus, B. B., Schneeberger, K., Vera, E., Tejera, A., Harley, C. B. and Blasco, M. A. 2011. The telomerase activator TA-65 elongates short telomeres and increases health span of adult/ old mice without increasing cancer incidence. Aging Cell 10, 604-621.
DOI
|
17 |
Deng, Z., Li, Y., Liu, H., Xiao, S., Li, L., Tian, J., Cheng, C., Zhang, G. and Zhang, F. 2019. The role of sirtuin 1 and its activator, resveratrol in osteoarthritis. Biosci. Rep. 39, BSR 20190189.
|
18 |
Donato, V., Ayala, F. R., Cogliati, S., Bauman, C., Costa, J. G., Lenini, C. and Grau, R. 2017. Bacillus subtilis biofilm extends Caenorhabditis elegans longevity through downregulation of the insulin-like signalling pathway. Nat. Commun. 8, 1-15.
DOI
|
19 |
Dow, C. T. and Harley, C. B. 2016. Evaluation of an oral telomerase activator for early age-related macular degeneration-a pilot study. Clin. Ophthalmol. (Auckland, NZ) 10, 243.
|
20 |
Fang, Y., Tang, S. and Li, X. 2019. Sirtuins in metabolic and epigenetic regulation of stem cells. Trends Endocrinol. Metab. 30, 177-188.
DOI
|
21 |
Galiniak, S., Aebisher, D. and Bartusik-Aebisher, D. 2019. Health benefits of resveratrol administration. Acta. Biochimica Polonica 66, 13-21.
|
22 |
Guan, Y., Wang, S. R., Huang, X. Z., Xie, Q. H., Xu, Y. Y., Shang, D. and Hao, C. M. 2017. Nicotinamide mononucleotide, an NAD+ precursor, rescues age-associated susceptibility to AKI in a sirtuin 1-dependent manner. J. Am. Soc. Nephrol. 28, 2337-2352.
DOI
|
23 |
Tsoukalas, D., Fragkiadaki, P., Docea, A. O., Alegakis, A. K., Sarandi, E., Thanasoula, M., Spandidos, D. A., Tsatsakis, A., Razgonova, M. P. and Calina, D. 2019. Discovery of potent telomerase activators: Unfolding new therapeutic and anti-aging perspectives. Mol. Med. Rep. 20, 3701-3708.
|
24 |
Valente, S., Mellini, P., Spallotta, F., Carafa, V., Nebbioso, A., Polletta, L., Carnevale, I., Saladini, S., Trisciuoglio, D. and Gabellini, C. 2016. 1, 4-Dihydropyridines active on the SIRT1/AMPK pathway ameliorate skin repair and mitochondrial function and exhibit inhibition of proliferation in cancer cells. J. Med. Chem. 59, 1471-1491.
DOI
|
25 |
Wang, Y., He, J., Liao, M., Hu, M., Li, W., Ouyang, H., Wang, X., Ye, T., Zhang, Y. and Ouyang, L. 2019. An overview of Sirtuins as potential therapeutic target: structure, function and modulators. Eur. J. Med. Chem. 161, 48-77.
DOI
|
26 |
Wyllie, F. S., Jones, C. J., Skinner, J. W., Haughton, M. F., Wallis, C., Wynford-Thomas, D., Faragher, R. G. and Kipling, D. 2000. Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet. 24, 16-17.
DOI
|
27 |
Zhu, Y., Doornebal, E. J., Pirtskhalava, T., Giorgadze, N., Wentworth, M., Fuhrmann-Stroissnigg, H., Niedernhofer, L. J., Robbins, P. D., Tchkonia, T. and Kirkland, J. L. 2017. New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging (Albany NY) 9, 955.
DOI
|
28 |
Zhu, Y., Liu, X., Ding, X., Wang, F. and Geng, X. 2019. Telomere and its role in the aging pathways: telomere shortening, cell senescence and mitochondria dysfunction. Biogerontology 20, 1-16.
DOI
|
29 |
Guarente, L. 2000. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 14, 1021-1026.
|
30 |
Guerrero, A., Guiho, R., Herranz, N., Uren, A., Withers, D. J., Martinez-Barbera, J. P., Tietze, L. F. and Gil, J. 2020. Galactose-modified duocarmycin prodrugs as senolytics. Aging Cell 19, e13133.
DOI
|
31 |
Gupta, S. D. and Pan, C. H. 2020. Recent update on discovery and development of Hsp90 inhibitors as senolytic agents. Int. J. Biol. Macromol. 161, 1086-1098.
DOI
|
32 |
Hardeland, R. 2019. Aging, melatonin, and the pro-and anti-inflammatory networks. Int. J. Mol. Cell Med. 20, 1223.
|
33 |
Harley, C. B., Liu, W., Flom, P. L. and Raffaele, J. M. 2013. A natural product telomerase activator as part of a health maintenance program: metabolic and cardiovascular response. Rejuvenation Res. 16, 386-395.
DOI
|
34 |
Kida, Y. and Goligorsky, M. S. 2016. Sirtuins, cell senescence, and vascular aging. Can. J. Cardiol. 32, 634-641.
DOI
|
35 |
Kirkland, J. L., Tchkonia, T., Zhu, Y., Niedernhofer, L. J. and Robbins, P. D. 2017. The clinical potential of senolytic drugs. J. Am. Geriatr. Soc. 65, 2297-2301.
DOI
|
36 |
Kiss, T., Nyul-Toth, A., Balasubramanian, P., Tarantini, S., Ahire, C., Yabluchanskiy, A., Csipo, T., Farkas, E., Wren, J. D. and Garman, L. 2020. Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects. Geroscience 42, 527-546.
DOI
|
37 |
Le Saux, C. J., Davy, P., Brampton, C., Ahuja, S. S., Fauce, S., Shivshankar, P., Nguyen, H., Ramaseshan, M., Tressler, R. and Pirot, Z. 2013. A novel telomerase activator suppresses lung damage in a murine model of idiopathic pulmonary fibrosis. PLoS One 8, e58423.
DOI
|
38 |
Li, H., Wei, C., Zhou, R., Wang, B., Zhang, Y., Shao, C. and Luo, Y. 2019. Mouse models in modeling aging and cancer. Exp. Gerontol. 120, 88-94.
DOI
|
39 |
Lin, C., Li, H., Liu, J., Hu, Q., Zhang, S., Zhang, N., Liu, L., Dai, Y., Cao, D. and Li, X. 2020. Arginine hypomethylation-mediated proteasomal degradation of histone H4-an early biomarker of cellular senescence. Cell Death Differ. 27, 2967-2709.
DOI
|
40 |
Liu, X., Belmonte, J. C. I., Zhang, W. and Liu, G. H. 2020. A -galactosidase kiss of death for senescent cells. Cell Res. 1-2.
|
41 |
Mai, A., Valente, S., Meade, S., Carafa, V., Tardugno, M., Nebbioso, A., Galmozzi, A., Mitro, N., De Fabiani, E. and Altucci, L. 2009. Study of 1, 4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors. J. Med. Chem. 52, 5496-5504.
DOI
|
42 |
Mishra, D. K., Prasad, R. and Yadava, P. 2020.Telomeres, Telomerase, and Aging.119-133. Models, Molecules and Mechanisms in Biogerontology: Springer.
|
43 |
Molgora, B., Bateman, R., Sweeney, G., Finger, D., Dimler, T., Effros, R. B. and Valenzuela, H. F. 2013. Functional assessment of pharmacological telomerase activators in human T cells. Cells 2, 57-66.
DOI
|
44 |
Morin, G. B. 1997. Telomere control of replicative lifespan. Exp. Gerontol. 32, 375-382.
DOI
|